Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer. Kurokawa R, Kato S, Koyama H, Ishida M, et al. Eur J Radiol 2022;157:110595.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kurokawa R, Kato S, Koyama H, Ishida M, et al. Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer. Eur J Radiol 2022;157:110595.
PMID: 36356462